To include your compound in the COVID-19 Resource Center, submit it here.

Ganetespib: Phase IIb/III started

Synta began the open-label, international Phase IIb/III GALAXY trial to compare 150 mg/m 2 IV

Read the full 159 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE